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tive visits between 9-15, 15-21, and 21-27 months after surgery were identified for
12-month, 18-month, and 24-month endpoints. All available data relating to the
procedure, demographics, comorbidities, and prior surgical history were consid-
ered as potential predictors of %BMI loss. Regressionmodels, usingmultiplemodel
selection procedures, were fitted at each endpoint. RESULTS: The population con-
sisted of 31,443 LAGB, 40,352 RYGB, and 2194 VSG patients, of whom 79% were
female, 79% were Caucasian, and the mean age was 46 years. Of the total 73,989
patients, 26,920 had a 12-month endpoint, 7245 had an 18-month endpoint, and
1774 had a 24-month endpoint. Regression models explained 37 to 55% of the
variance in %BMI loss, depending primarily on the endpoint, with the highest
percent variance explained at the 12-month endpoint and the lowest at the 24-
month endpoint. Model selection methods made little difference in model fit. The
type of bariatric surgery performed was the most significant predictor in all mod-
els. Other significant predictors in various models included key demographic vari-
ables and comorbidities, as well as baseline BMI. CONCLUSIONS: The data in the
BOLD registry are sufficiently robust to enable the evaluation of predictors of bari-
atric surgery success including surgery type, comorbidities, baseline BMI and key
demographic variables.
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OBJECTIVES: To explore the feasibility of using linked hospital discharge and vital
statistics death records to study the comparative effectiveness of repairs for un-
ruptured abdominal aortic aneurysm (AAA) using traditional open aortic repair
(OAR) and endovascular aortic repair (EVAR).METHODS: Linked hospital discharge
and vital statistics death records of the California Office of Statewide Health Plan-
ning andDevelopmentwere used for 2000-2007. Hospitalized patients for AAAwith
OAR and those with EVAR were identified. Demographic characteristics, comor-
bidities, the rates of complication, mortality, readmissions were compared be-
tween these two groups. Descriptive statistics, Kaplan-Meier survival analysis, and
propensity scores were used. RESULTS:We identified 8343 AAA patients with OAR
and 6221 AAA patients with EVAR between 2000Q3 and 2007. The yearly number of
OARs declined from 1,766 to 80, while EVARs increased from 676 to 1,389. Patients
receiving OAR were more acutely ill and likely to be admitted through ED than
those with EVAR (8.5% vs. 2.8%). Preliminary results indicated that the inpatient
mortality rate was higher for OAR than EVAR (4.68 vs. 0.96 per 100; P  0.001). The
30 day post-dischargemortality rateswithOARwas not significantly different from
EVAR (0.49 vs. 0.32 per 100; P  0.127). CONCLUSIONS: The information generated
from the linked discharge and death data will be useful in developing hypotheses,
describing patients and trends, and obtaining fast, preliminary indications of the
effectiveness and safety of alternative treatments. Although we found issues with
the data quality about which data users need to be vigilant, these concerns do not
negate the potential value of the data as an important adjunct and precursor to
more expensive clinical trials. The strength of this observational analysis derives
from the inclusion of all hospital stays for intact AAA as compared to the selected
samples that often comprise randomized clinical trials.
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PREVALENCE OF CARDIOVASCULAR RISK FACTORS AMONG PATIENTS
UNDERGOING ELECTIVE CORONARY ARTERY BYPASS SURGERY
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OBJECTIVES: Globally 80% cardiovascular disease deaths occurred in low andmid-
dle income countries with almost equal proportion inboth gender. Evidence shows
that people in low andmiddle income countries are more exposed to cardiovascu-
lar risk factors while less exposed to preventivemeasures. It may lead to long
course of management by either/ both medical and surgical techniques including
coronary artery bypass surgery, increasing the economic burden.In order to find
avenue for prevention, we aimed to measure the prevalence of cardiovascular risk
factors among patients undergoing elective CABG in Karachi, Pakistan.METHODS:
Information was collected through structured questionnaire and entered into Mi-
crosoft Access software. On the basis of research hypotheses, specific data chunk
was extracted and analyzed in SPSS 19. RESULTS: In this retrospective chart re-
view, 2073 patient undergoing elective CABG between January 2006 to June 2011
were included. Mean age of the patients was 54.859.7 years. Out of all, 14.7%
patients were females.Family history was present in 53%, 47.7% were smokers.
Conventional risk factors of overweight was 47.10%, obese was 14.7%,diabetes was
47.7%, hypertension was 69.50%, dyslipidemiawas 50.20%,renal failure was 9.2%
and prior MI was 46.7%. Outcomes includeoperative mortality of 0.3% while14.8%,
renal failure, 7% arrhythmias, 2.3% reoperation and 3.1% prolonged ventilation as
postoperative complications. CONCLUSIONS: There is a high prevalence among
patients undergoing elective CABG of coronary risk factors including dyslipidemia,
hypertension, diabetes and smoking.
SURGERY – Cost Studies
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OBJECTIVES: The objective of this analysis is to assess impact on hospital costs for
a patient using sugammadex for reversal of deep neuromuscular blockade com-
pared to no reversal agent.METHODS: An economic model reflecting resource use
and costs associated with neuromuscular block and its reversal, and residual
blockade, was constructed for the Swedish healthcare setting. Sugammadex was
compared to no reversal as other reversal agents are ineffective in reversing deep
block. Clinical trial data were used to estimate time savings relating to shortened
reversal in the operating room (OR). Costs of OR timewere derived from labor costs
for different types of OR staff. Resource use associated with clinical sequelae of
residual blockade (aspiration, hypoxemia, muscle weakness, upper airway ob-
struction) was estimated from the literature, where available. Unit costs were
taken from published pricelists of the state-owned pharmacy chain and, published
hospital price lists. RESULTS: If all OR staffmodeled (anesthetist, two surgeons and
two nurses) can be re-allocated to realize time savingswith shortened reversal, use
of Sugammadex compared to no reversal of deep neuromuscular blockade is esti-
mated to save 353 SEK per reversed patient. This corresponds to an increase in
drug costs of 1953 SEK, which is more than fully offset by a decrease in the costs of
OR staff time and clinical sequelae of residual blockade (-2306 SEK). In a worst case
scenario, if only the anesthetist, one surgeon and one nurse realize time savings,
costs would be increased (594 SEK) compared to no reversal. Results were sensitive
to OR staff costs and time savings. CONCLUSIONS: Sugammadex for reversal of
deep neuromuscular blockade can potentially lead to cost savings in the Swedish
health care setting. The degree to which costs may be saved depends upon which
OR staff are able to redeploy to other activities with shortened reversal.
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OBJECTIVES: This study was to estimate economic burden of obesity and to assess
the impact of bariatric surgery on health care costs and utilization in adults in
Alberta.METHODS:Multivariate regressionmodelswere developed to estimate the
impact of BMI on physician, outpatient and inpatient costs and visits. A pre-post
analysis over a 5-year period was conducted to compare the cost and visits before
and after surgery. Patients who received bariatric surgery in 2006 were identified
using the the Canadian Classification of Health Interventions (CCI) codes that cor-
respond to bariatric surgery. Total physician, inpatient and outpatient costs and
visits were calculated across all patients, over a period of two years before and two
years after surgery. Health utilization data from Alberta provincial health admin-
istrative databases were linked with epidemiologic and demographic data con-
tained in Canadian Community Health Survey (CCHS). RESULTS:When combining
physician and outpatient costs, the mean estimate per obese resident was $696,
following by $545 for overweight, $523 for underweight, and $480 for normalweight
residents. Compared to normal weight, obesity, overweight and underweight were
associated with increases of $217, $65 and $44, respectively. There were 217 bari-
atric surgery recipients in 2006. Health care costs and utilization two years pre-
surgery were greater than two years post-surgery. The marginal change in health
care costs and utilization between 2004 and 2005, however, was positive, indicating
an increase prior to surgery. In contrast, the marginal change in health care costs
and utilization was negative, indicating a decrease post-surgery. The estimate of
total physician and hospital costs associated with bariatric surgery was $12,175.79
(SE: $586.75). CONCLUSIONS: Obesity placed a large economic burden on health
care system. The bariatric surgery may alter the upward trajectory of health utili-
zation for severely obese patients. Further research including longer follow-up
period is necessary to confirm the impact of bariatric surgery.
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OBJECTIVES: Incidence of total knee arthroplasties (TKAs) increased from 31.2 to
220.9 per 100,000 person-years in the US from 1971-1976 to 2005-2008. Muscle at-
rophy/weakness pre- or post-TKA surgery is associated with poor postoperative
function. This review assessed disease burden andmedical needs in older patients
with TKA and muscle atrophy/weakness in US, Canada, Australia, and five major
countries in Europe.METHODS: Using keywords related to muscle atrophy/weak-
ness and TKA, we systematically searched English-language, MEDLINE- or EM-
BASE-indexed literature published fromMay 2001 to May 2011 andmaterials avail-
able from governmental or professional organizations. Selected articles focused on
epidemiologic, economic, humanistic, and treatment burden of muscle atrophy/
weakness (defined as evaluations of muscle atrophy, strength, or performance) in
adults ages 50 with TKA. Excluded articles were molecular and genetic studies,
case reports, and evaluations of muscle atrophy/weakness in 20 patients.
RESULTS: Eighty-three articleswere included. Strength and function improve from
preoperative baseline starting 3-4 months postoperatively but remain impaired
compared with healthy controls. Postoperative physical therapy (PT), exercise, or
electrical muscle stimulation improve strength and performance and accelerate
recovery; however, operated limbs may never regain strength to match healthy
controls or non-operated limbs. Preoperative exercise and education (Canada) or
inpatient aquatic PT (Australia) do not reduce hospital length of stay versus usual
care. Guidelines and real-world treatment pattern studies do not address optimal
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PT regimens and settings. Few studies investigated effectiveness of pharmacolog-
ical interventions for improving strength and performance. No studies estimated
the incidence, prevalence, or direct or indirect cost of muscle atrophy/weakness in
TKA. CONCLUSIONS: The impact of muscle atrophy/weakness on the cost and
treatment of TKA is poorly defined; few rehabilitation strategies fully restore
strength and function. Future research may need to evaluate the contribution of
muscle atrophy/weakness to TKA disease burden and determine optimal interven-
tions for recovery of strength and function.
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CARE: AN ECONOMIC EVALUATION OF THE RAPID RECOVERY PROGRAMME
(RRP)
Jørgensen E1, Suseg P2
1Biomet Nordic, Oslo, Norway, 2LINK Medical Research AS, Oslo, Norway
OBJECTIVES: The objective of this evaluation was to analyze the economic impact
of introducing the RRP – a program that optimizes all aspects of a patient’s journey
from pre-operative assessment to discharge and beyond, which improves patient
satisfaction of patients undergoing primary hip and knee arthroplasty, in the Nor-
wegian South-Eastern Regional Health Authority (SENRHA). METHODS: An eco-
nomic model was developed using empirical data from a retrospective evaluation
of the RRP at the public-run London based Hillingdon Hospital Trust. The model
compared the two scenarios pre- and post-implementation of the RRP where the
former scenario constituted the current clinical practice of the SENRHA and the
lattermodeled the impact of the RRP on the SENRHA by assuming transferability of
the Hillingdon results, as they are reproduced in a model developed by the Berkely
Partnership in cooperation with the hospital. The model used in this analysis syn-
thesizes the evidence from Hillingdon with Norwegian cost and LOS data. The
pre-RRP number of patients and LOS at the SENRHA were retrieved from the Nor-
wegian Patients Registry. Cost components including staff, theatre, prosthetics,
drugs, bed days, pathology and diagnostics were collected from publicly available
sources. Benefits were estimated using the Norwegian DRG-based public funding
system. The SENRHA is one of four regional Norwegian health authorities serving a
population base of 2.8 million inhabitants. RESULTS: The model predicts a 58%
reduction in LOS for patients undergoing primary hip and knee arthroplasty and
estimate a volume increase of 92% for arthroplastic surgeries. Due to a reduction in
average cost per case and increased capacity, the overall change in SENRHA‘s net
position is estimated to 70 million US dollars. CONCLUSIONS: The model suggests
that implementing the Rapid Recovery Programme in the Norwegian South-East-
ern Regional Health Authority (SENRHA) is highly cost effective.
PSU10
COMPARATIVE COST-EFFECTIVENESS ANALYSIS OF COFLEX INTERLAMINAR
STABILIZATION VERSUS POSTEROLATERAL FUSION FOR LUMBAR STENOSIS
AND LOW-GRADE SPONDYLOLISTHESIS
Auerbach JD1, Zigler JD2, Yeung A3, Davis RJ4, Pettine K5
1Bronx-Lebanon Hospital Center, Bronx, NY, USA, 2Musculoskeletal Clinical Regulatory Advisers,
LLC, Washington, DC, USA, 3Desert Institute for Spine Care, Phoenix, AZ, USA, 4Greater
Baltimore Medical Center, Baltimore, MD, USA, 5The Loveland Surgery Center, Loveland, CO,
USA
OBJECTIVES: Lumbar spinal fusion for treatment of spinal stenosis with back pain
and spondylolisthesis has potential for perioperative morbidity, adjacent segment
degeneration, and increased costs which have led to the investigation into less-
invasive alternative treatments. Analysis of two-year results from randomized,
controlled clinical study comparing coflex interlaminar stabilization surgery with
posterolateral spinal fusion (PLF) surgery for stenosis with spondylolisthesis dem-
onstrated clinical equivalence or superiority with coflex, and showed clear superi-
ority in perioperative outcomes. The objective of this study is to determinewhether
the actual cost of coflex procedures is favorable to PLF, as a result of decreased
resource utilization. METHODS: Actual cost of care data was available for 62 pa-
tients across 3 of the 20 sites that participated in the clinical trial comparing coflex
with PLF. Actual facility costs for each case were calculated as 2011 USD, reported
as OR costs, recovery room costs, implant costs, supplies, drugs, and medical
equipment. Assumptions of cost for implants included 1) $4-8,000 per coflex de-
vice, and 2) PLF implant costs range: $7-11,000 for 1-level, and $10-14,000 for 2-level.
RESULTS: Average blood loss, hospital stay, and OR time were substantially lower
with coflex. Based on actual costs to facilities examined, a 1-level coflex procedure
saved on average $8776 peri-operatively, compared with 1-level PLF. Similarly, a
2-level coflex procedure saved $4702 comparedwith 2-level PLF. For these patients,
%ODI improvement was similar among the 4 cohorts at 2 years: 1-level coflex
(59.5%), 1-level fusion (38.0%), 2-level coflex (63.3%), 2-level fusion (64.1%).
CONCLUSIONS: On average, 1-level coflex procedures saved $8776 per case, while
2-level coflex procedures saved on average $4702 compared with fusion, while
producing similar or improved clinical outcomes at 2 years. Our data suggest the
potential for substantial cost-savings with coflex interlaminar stabilization com-
pared with fusion in the treatment of spinal stenosis and spondylolisthesis.
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OBJECTIVES: Video-Assisted Thoratic Surgical (VATS) lobectomies and wedge re-
sections result in lower morbidity and shorter length of stay (LOS) than open tho-
racotomy. The impact of robotic-assisted VATS on clinical and economic out-
comes, however, has not been examined. This study compared hospital costs and
clinical outcomes for VATS lobectomies and wedge resections with and without
robotic assistance.METHODS: Using the Premier hospital database, patients aged
18 years with a record of thoracoscopic lobectomy (ICD-9 code 32.41), thoraco-
scopic segemental resection of lung (ICD-9 code 32.30), or thoracoscopic excision of
lesion or tissue of lung (ICD-9 code 32.20) between 2009 to Q2 2011 were identified.
Procedures utilizing robotic technology were identified if one of two conditions
weremet: (1) a robotic ICD-9 procedure code accompanied the procedure of interest
or (2) “text” fields in the hospital charge master file indicated use of robot. Data
were collected on intra-operative and post-operative complications, LOS, readmis-
sion rates, and total hospital cost for the procedures. Bivariate comparisons be-
tween VATS procedures with/without robotic assistance used MannWhiteny-U to
test for differences in median costs and surgery times. RESULTS: Of 15,502 patient
records analyzed, 96% (n14,837) were performed without robotic assistance. Us-
ing robotic assistancewas associatedwith highermedian per patient hospital costs
(not including robotic capital or service contract). Median cost of inpatient proce-
dures with/without robotic assistance was $22,331 versus $17,667 (p0.0001) for
lobectomies and $17,369 versus 13,574 (p0.0001) for wedge resections respec-
tively. Median inpatient surgery times were not significantly different for lobec-
tomy (4.03 versus 4.00) but where longer for wedge resection. Surgery hours for
robotic wedge resection versus non-robotic were 2.92 versus 2.25 (p0.0001), re-
spectively. Median LOS was similar across both groups. CONCLUSIONS: Based on
this analysis, robotic-assisted VATS for lobectomy and wedge resection appears to
have higher hospital costs and wedge resections have longer surgery times.
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OBJECTIVES: To compare clinical and economic outcomes for conventional lapa-
roscopic (LAP) and robotic assisted minimally invasive surgery for segmental
colectomies.METHODS: Using the Premier hospital database patients 18 years
of age having one of the following primary LAP colectomies performed in 2009 toQ2
2011 were identified: cecectomy, hemi colectomy, left hemi colectomy, and sig-
moidectomy. Those procedures utilizing robotic technology were identified if one
of two conditions were met: 1) A robotic ICD-9 procedure code accompanied the
primary procedure of interest, or 2) “text” fields in the hospital charge master file
indicated use of the robot. Patients were matched on laparoscopic versus robotic
colectomy using a propensity score on severity, certain demographic and hospital
characteristics, and 1:1 on type of procedure. The association between robot-as-
sisted colectomy and adverse events, hospital costs, surgery time, and length of
stay was examined. RESULTS: Of 25,758 patient records from 364 hospitals, 98%
(n25,210) of laparoscopic colectomieswere performedwithout robotic assistance;
2% (548) with robotic assistance. After matching, 1,066 patients remained, 533 in
each group. No significant differences existed between the matched cohorts for
major, minor and/or surgical complications. Use of the robot was associated with
statistically higher mean per patient hospital costs. Inpatient procedures with and
without robot assistance cost $17,445 vs. $15,447 (p0.0008) respectively. The anal-
ysis did not include capital costs or service fees associated with maintaining the
robot. Inpatient surgery times were significantly longer for robot-assisted proce-
dures thannon-robot procedures (4.37 vs. 3.34 hours; p0.0001). Length of staywas
similar. CONCLUSIONS: Findings reveal minimal clinical differences in peri and
post-operative events and length of stay. There were significant increases in cost
per case and OR time for robotic assisted versus conventional LAP procedures.
These results call into question the cost-effectiveness of this technology in these
procedures.
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OBJECTIVES: Perioperative red cell salvage (CS) – the process of collecting shed
blood during surgery and returning it to patients - reduces the need for allogeneic
blood transfusion, which results in fewer transfusion-related adverse events and
consequently more quality-adjusted life years compared to surgery without CS.
However, little is known about the cost of CS in pediatric surgery. Our objectivewas
to compare the societal costs associated with four transfusion strategies among
patients undergoing elective orthopedic or cardiac surgery in Children’s Hospital
Boston: 1) CS followed by autologous transfusion; 2) CS followed by allogeneic
transfusion; 3) autologous transfusion alone; and 4) allogeneic transfusion alone.
METHODS: A TreeAge © decision tree was used to conduct all comparisons (2010
dollars), threshold analyses, univariate and multivariate probabilistic sensitivity
analyses. The CS-related and blood processing direct, indirect and labor costs/
patientwere obtained from the hospital accounting records and the cost of a unit of
red blood cells (RBC), from nationally representative reports. Probabilities of blood
transfusion after CS and the number of RBC units returned via CS were obtained
from hospital utilization records. The probabilities and lifetime costs of a range of
infections and reactions caused by allogeneic transfusion were derived from pub-
lished sources. RESULTS: Average CS, blood processing and RBC unit costs were
$160, $1895 and $223, respectively. Average volume of blood returned via CS was
271cc, and the probability of needing transfusion after CS was 0.80. Cell salvage
with autologous blood transfusion ($1504) was least expensive, followed by CSwith
A75V A L U E I N H E A L T H 1 5 ( 2 0 1 2 ) A 1 – A 2 5 6
